2016
DOI: 10.1016/j.ijrobp.2016.06.141
|View full text |Cite
|
Sign up to set email alerts
|

Somatic ERCC2 Mutations Are Associated With a Distinct Mutational Signature in Muscle-Invasive Bladder Cancer

Abstract: required to delineate dose-response-associated RNA profiles in radiation-induced EVs, and to define tumor-and tissue-specific biodosimetric signatures. Conclusion: EVs have tremendous potential as biomarkers and regulators of disease. NanoFACS offers a unique platform for the analysis and separation of tumor/tissue-specific and treatment-associated EV subsets. Future studies will investigate whether nanoFACS can be used to identify EV subsets associated with tumor growth, anti-tumor immune responses, and resis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The study described 21 different mutational signatures, each characterised by different proportions of the 96 types. Subsequently more than 30 signatures, many with tumour type-specificity, have been reported [6][7][8][9][10][11] .…”
Section: Introductionmentioning
confidence: 99%
“…The study described 21 different mutational signatures, each characterised by different proportions of the 96 types. Subsequently more than 30 signatures, many with tumour type-specificity, have been reported [6][7][8][9][10][11] .…”
Section: Introductionmentioning
confidence: 99%